SCHEMBL23997489

SCHEMBL23997489

Cc1cc(C)c(S(=O)(=O)N(C)CC(CO)CN(C)S(=O)(=O)c2c(C)cc(C)cc2C)c(C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.43
MAPT P10636 2/20 0.41
GLA P06280 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40
KEAP1 Q14145 2/20 0.39
NFE2L2 Q16236 2/20 0.39
NPSR1 Q6W5P4 1/20 0.37
F2 P00734 2/20 0.37
PRSS1 P07477 2/20 0.37
PRSS2 P07478 2/20 0.37
PRSS3 P35030 2/20 0.37
NR3C1 P04150 1/20 0.36
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23997478 0.81 PKM (0.39) PKMMAPTGLAL3MBTL1CA1
SCHEMBL23997611 0.79 PKM (0.38) PKMMAPTGLAL3MBTL1CA1
SCHEMBL3440343 0.78 PKM (0.46) PKMMAPTGLAL3MBTL1CA1
SCHEMBL17296533 0.73 KEAP1 (0.57) PKMMAPTGLAL3MBTL1CA1
SCHEMBL11441166 0.73 PKM (0.42) PKMMAPTGLAL3MBTL1CA1
SCHEMBL7516914 0.71 PKM (0.43) PKMMAPTGLAL3MBTL1CA1
SCHEMBL11437189 0.71 PKM (0.41) PKMMAPTGLAL3MBTL1CA1
SCHEMBL3440362 0.69 ALDH1A1 (0.43) PKMALDH1A1BDKRB1
SCHEMBL4894187 0.68 PKM (0.49) PKMMAPTGLAL3MBTL1CA1
SCHEMBL14191074 0.67 MMP1 (0.45) PKMMAPTCA1CA2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174562-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS Tonix Pharmaceuticals, Inc. 2023-06-08 US disclosed
US-20230174562-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS Tonix Pharmaceuticals, Inc. 2023-06-08 US disclosed
US-20230138150-A1 RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS Tonix Pharmaceuticals, Inc. 2023-05-04 US disclosed
US-20230138150-A1 RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS Tonix Pharmaceuticals, Inc. 2023-05-04 US disclosed
US-11566032-B2 Radio-protective and chemo-protective substituted thiols Tonix Pharmaceuticals, Inc. (US) 2023-01-31 US disclosed
US-20210388011-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS TONIX PHARMACEUTICALS HOLDING CORP. 2021-12-16 US disclosed
WO-2021226559-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS Tonix Pharmaceuticals, Inc. (US) 2021-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174562-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS MGMT, RCOR3, TSPO PKM 1157/4885MAPT 3787/4885GLA 1060/4885
US-20210388011-A1 RADIO-AND CHEMO-PROTECTIVE COMPOUNDS MGMT, GSTP1, GSTA1 PKM 2860/4885MAPT 4655/4885GLA 1505/4885
US-11566032-B2 Radio-protective and chemo-protective substituted thiols MGMT, GSTP1, GSTA1 PKM 2829/4885MAPT 4671/4885GLA 2118/4885
US-20230138150-A1 RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS MGMT, GSTA1, GSTP1 PKM 2671/4885MAPT 4705/4885GLA 1853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.